雅各臣科研制药(02633.HK)拟11月18日举行董事会会议审批中期业绩
Core Viewpoint - Jacobson Pharmaceutical Holdings (02633.HK) has announced a board meeting scheduled for November 18, 2025, to consider and approve the interim results for the six months ending September 30, 2025, and to discuss the potential distribution of an interim dividend, among other matters [1] Group 1 - The board meeting will focus on the interim performance of the company and its subsidiaries [1] - The meeting will also address the potential declaration of an interim dividend, if applicable [1] - The date of the board meeting is set for November 18, 2025 [1]